Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid receptor antagonism with methylnaltrexone in acute pancreatitis
2020-002313-18Phase 2Completed
- Sponsor
- Mech-Sense
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute pancreatitis (AP) comparing Methylnaltrexone (Relistor) arm with Placebo arm (2 arms). Started Nov 2020; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on 2020-002313-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002313-18.